-
Man Utd agree deal for Brighton midfielder Baleba: reports
-
US, Canada push to seal trade deal as deadline nears
-
Werro wins Lausanne 800m, well off world record pace
-
One dead, three wounded after sword attack at Swedish high school
-
China mulls bid to host 2028 UN climate talks: sources
-
Ukraine says 'cynical' Russian strike on shopping centre killed 15
-
Jones becomes third Englishman to join Inter this summer
-
US Supreme Court allows White House ballroom construction for now
-
Mexican governor wanted on US drug charges returns to job
-
Root hails emerging fast bowlers as England thrash Pakistan
-
Bolivia's Paz forced to fire economy minister in mid-crisis
-
Brazil's Lula urges tariffs resolution in call with Trump
-
A-Rod ups T-Wolves stake in $4.5bn ownership change
-
Ukraine says 'cynical' Russian strike on shopping centre killed 14
-
UK court orders Prince Harry, others to pay Daily Mail initial £9.5mn
-
Heatwave-hit Europe logs over 30,000 excess summer deaths: first figures
-
'Grateful' ex-world champion Alaphilippe retires from cycling
-
Give LIV Golf 'one more shot,' says DeChambeau
-
US, Canada work to wrap up trade deal ahead of looming deadline
-
Duplantis hits the high notes for athletics anthem
-
Malaysia's JDT claim unbeaten run world record
-
Malaysia's JDT claims unbeaten run world record
-
At least 2 teens seriously wounded in sword attack at Swedish school
-
Bolivian economy minister fired after Congress vote
-
Popular forest near Paris to reopen after wildfire
-
Russell roars to Dutch GP sprint pole, Antonelli fifth
-
UN holds second informal poll of secretary-general candidates
-
Russell takes pole for Dutch GP sprint
-
Shakhtar Donetsk to play Champions League home games at Chelsea
-
England start life after Bazball with rout of Pakistan
-
Arsenal sign Villa centre-back Konsa as champions bolster defence
-
'Duck run' pest control catching on in S.Africa's winelands
-
The 'hedgehogs' leading Poland's defences on Russian border
-
UK, Canada, Australia slam Israel ending probe into aid worker killings
-
England thrash Pakistan by an innings and 103 runs in first Test
-
Spurs spending spree vital to raise standards: De Zerbi
-
Fury says Joshua fight 'doesn't look like it's going to happen'
-
US, Canada try to wrap up trade deal before latest Trump deadline
-
Argentina's Paredes suspended 10 matches by FIFA for World Cup fight
-
World No.1 Sinner withdraws from US Open with knee injury
-
Watkins and Martinez could join Villa exodus says Emery
-
Judge allows UK rugby brain injury court case to continue to trial
-
UK court orders Prince Harry, others to pay Daily Mail £9.5mn
-
Trump announces temporary tariff relief on ground beef imports
-
Aligned Launches $ALIGN, the Native Token of Its Full Ethereum Stack
-
Pope to visit San Marino, address Italian political event
-
Bitcoin jumps, stocks bounce as traders weigh US Treasury action
-
All Blacks just as good as Springboks, says captain Savea
-
Man City boss Maresca hit with Doku injury blow
-
Romania holding suspected 'low-level agent' after pistols found near Berlin: Germany
US approves sale of anti-overdose drug Narcan without prescription
The US drug regulator announced Wednesday that Narcan, the treatment which reverses overdoses, can be distributed without prescription, a move that comes as the country battles an acute opioid addiction crisis.
The Federal Drug Administration (FDA) said that four milligram nasal spray doses of naloxone hydrochloride, the generic name for Narcan, can be sold over the counter almost anywhere, from pharmacies to supermarkets to gas stations.
The FDA said they moved to address to mounting toll from opioid use, especially the synthetic and relatively easily made fentanyl, which has in the past five years increasingly replaced heroin and prescription pain killers as the main drug used by people addicted to opioids.
In the 12 months to October 2022, the US recorded 101,750 overdose deaths, mostly from fentanyl, the FDA said in a statement.
"The agency has used its regulatory authority to facilitate greater access to naloxone by encouraging the development of and approving an over-the-counter naloxone product to address the dire public health need,” said FDA Commissioner Robert Califf.
Narcan, by far the most commonly used version of naloxone, can quickly reverse the effects of an overdose.
Narcan will "bring someone back from basically the dead," Johnny Bailey, who has recovered from an opioid addiction and who trains people to administer the drug, explained in early March in Washington.
Previously administered mainly by injection, Narcan, produced by Emergent BioSolutions, was approved in its nasal spray form as a prescription drug in 2015.
With the toll from overdoses mounting each year, the FDA accelerated its review of Narcan for over-the-counter sales early this year.
The FDA said other producers of naloxone spray can gain approval on a case-by-case basis.
"Naloxone is a critical tool in addressing opioid overdoses," said FDA drug evaluation chief Patrizia Cavazzoni.
D.AbuRida--SF-PST